The document discusses various tumors and conditions of the small intestine. The common benign and malignant tumors of the small intestine are listed. Details are provided about carcinoid tumors, including their classification and characteristics. Megaolon is described as a dilatation of the colon that can be congenital or acquired. Hirschsprung's disease is mentioned as a congenital form. Other topics covered include the carcinoid syndrome, Meckel's diverticulum, volvulus, and intussusception - the telescoping of one segment of intestine into another.
This document summarizes information about gastric carcinoma (stomach cancer). It covers the epidemiology, anatomy, pathology, risk factors, clinical presentation, staging, and treatment of gastric cancer. Key points include:
- Gastric cancer was previously a leading cause of cancer death but now ranks fourth most common. Incidence is highest in China and Japan.
- The stomach has extensive lymphatic drainage involving 16 lymph node stations.
- 95% of gastric cancers are adenocarcinomas. Other rare types include squamous cell carcinoma and carcinoid tumors.
- Risk factors include smoking, obesity, and H. pylori infection. Symptoms are often vague but may include weight loss, abdominal pain,
Inflammatory bowel disease (IBD) refers to chronic inflammation of the intestinal tract. The two major types are ulcerative colitis (UC), which involves the inner lining of the large intestine, and Crohn's disease (CD), which can impact any part of the gastrointestinal tract from mouth to anus. IBD results from an abnormal immune response to intestinal bacteria in a genetically susceptible individual. Symptoms vary depending on the specific type and location of disease but commonly include diarrhea, abdominal pain, and rectal bleeding. Diagnosis involves blood tests, endoscopy, imaging, and biopsy to characterize inflammation and differentiate IBD from other conditions. Treatment aims to induce and maintain remission through medications, surgery, or other approaches depending on
Colonic adenomas are benign epithelial tumors that can develop into colorectal cancer over time. They range in size and can be pedunculated or sessile. Microscopically, they are characterized by epithelial dysplasia and nuclear abnormalities. Certain familial polyposis syndromes, like familial adenomatous polyposis and Lynch syndrome, are associated with an increased risk of developing numerous colonic adenomas and colorectal cancer at a young age due to genetic mutations. Surveillance colonoscopy is recommended to screen for and remove adenomas to prevent cancer.
Liver lesions benign and malignant and treatment options.pptxAbd266
This document discusses benign and malignant liver lesions and their treatment options. For benign lesions, it covers hemangioma, focal nodular hyperplasia, liver cysts, and hepatic adenoma. It describes their symptoms, diagnostic imaging findings, and treatments. For malignant lesions, it focuses on hepatocellular carcinoma (HCC). It discusses the risk factors, pathogenesis, presentations, diagnostic workup including CT and AFP levels, staging systems like BCLC, and treatment options for HCC such as resection, transplantation, ablation, and chemoembolization. It also briefly mentions colon cancer often metastasizing to the liver.
The document discusses breast pathology and benign breast diseases. It begins by describing the anatomy of the breast including lobes, lobules, acini, and ducts. It then discusses clinical presentations of benign breast diseases such as pain, palpable masses, and nipple discharge. Various benign breast lesions are outlined including inflammatory conditions, benign epithelial lesions (nonproliferative changes, proliferative disease without atypia, and proliferative disease with atypia), and breast tumors. Risk of subsequent breast cancer is higher for proliferative disease with atypia compared to other benign breast conditions.
This document outlines ulcerative colitis (UC), an idiopathic inflammatory bowel disease that involves the colonic mucosa. It commonly affects the rectum and may extend proximally in a continuous pattern. UC is characterized by relapsing and remitting inflammation. The document discusses the epidemiology, pathophysiology, clinical features, investigations, severity indices, and medical and surgical management approaches for UC. Key points include that UC has a bimodal age of onset, involves the colonic mucosa continuously from the rectum up, and is managed primarily through aminosalicylates and immunosuppressants with surgery reserved for severe cases unresponsive to medical therapy.
The gallbladder is a pear-shaped organ that stores and concentrates bile produced by the liver. It can be affected by various congenital anomalies and gallstones. Gallstones are usually cholesterol stones but some may be pigment stones related to hemolytic conditions. Cholecystitis, or inflammation of the gallbladder, can be acute or chronic and is usually caused by gallstones. Gallbladder cancer is rare but associated with conditions like gallstones and chronic infection. Cancers can also occur in the bile ducts and ampulla of Vater.
The document discusses various tumors and conditions of the small intestine. The common benign and malignant tumors of the small intestine are listed. Details are provided about carcinoid tumors, including their classification and characteristics. Megaolon is described as a dilatation of the colon that can be congenital or acquired. Hirschsprung's disease is mentioned as a congenital form. Other topics covered include the carcinoid syndrome, Meckel's diverticulum, volvulus, and intussusception - the telescoping of one segment of intestine into another.
This document summarizes information about gastric carcinoma (stomach cancer). It covers the epidemiology, anatomy, pathology, risk factors, clinical presentation, staging, and treatment of gastric cancer. Key points include:
- Gastric cancer was previously a leading cause of cancer death but now ranks fourth most common. Incidence is highest in China and Japan.
- The stomach has extensive lymphatic drainage involving 16 lymph node stations.
- 95% of gastric cancers are adenocarcinomas. Other rare types include squamous cell carcinoma and carcinoid tumors.
- Risk factors include smoking, obesity, and H. pylori infection. Symptoms are often vague but may include weight loss, abdominal pain,
Inflammatory bowel disease (IBD) refers to chronic inflammation of the intestinal tract. The two major types are ulcerative colitis (UC), which involves the inner lining of the large intestine, and Crohn's disease (CD), which can impact any part of the gastrointestinal tract from mouth to anus. IBD results from an abnormal immune response to intestinal bacteria in a genetically susceptible individual. Symptoms vary depending on the specific type and location of disease but commonly include diarrhea, abdominal pain, and rectal bleeding. Diagnosis involves blood tests, endoscopy, imaging, and biopsy to characterize inflammation and differentiate IBD from other conditions. Treatment aims to induce and maintain remission through medications, surgery, or other approaches depending on
Colonic adenomas are benign epithelial tumors that can develop into colorectal cancer over time. They range in size and can be pedunculated or sessile. Microscopically, they are characterized by epithelial dysplasia and nuclear abnormalities. Certain familial polyposis syndromes, like familial adenomatous polyposis and Lynch syndrome, are associated with an increased risk of developing numerous colonic adenomas and colorectal cancer at a young age due to genetic mutations. Surveillance colonoscopy is recommended to screen for and remove adenomas to prevent cancer.
Liver lesions benign and malignant and treatment options.pptxAbd266
This document discusses benign and malignant liver lesions and their treatment options. For benign lesions, it covers hemangioma, focal nodular hyperplasia, liver cysts, and hepatic adenoma. It describes their symptoms, diagnostic imaging findings, and treatments. For malignant lesions, it focuses on hepatocellular carcinoma (HCC). It discusses the risk factors, pathogenesis, presentations, diagnostic workup including CT and AFP levels, staging systems like BCLC, and treatment options for HCC such as resection, transplantation, ablation, and chemoembolization. It also briefly mentions colon cancer often metastasizing to the liver.
The document discusses breast pathology and benign breast diseases. It begins by describing the anatomy of the breast including lobes, lobules, acini, and ducts. It then discusses clinical presentations of benign breast diseases such as pain, palpable masses, and nipple discharge. Various benign breast lesions are outlined including inflammatory conditions, benign epithelial lesions (nonproliferative changes, proliferative disease without atypia, and proliferative disease with atypia), and breast tumors. Risk of subsequent breast cancer is higher for proliferative disease with atypia compared to other benign breast conditions.
This document outlines ulcerative colitis (UC), an idiopathic inflammatory bowel disease that involves the colonic mucosa. It commonly affects the rectum and may extend proximally in a continuous pattern. UC is characterized by relapsing and remitting inflammation. The document discusses the epidemiology, pathophysiology, clinical features, investigations, severity indices, and medical and surgical management approaches for UC. Key points include that UC has a bimodal age of onset, involves the colonic mucosa continuously from the rectum up, and is managed primarily through aminosalicylates and immunosuppressants with surgery reserved for severe cases unresponsive to medical therapy.
The gallbladder is a pear-shaped organ that stores and concentrates bile produced by the liver. It can be affected by various congenital anomalies and gallstones. Gallstones are usually cholesterol stones but some may be pigment stones related to hemolytic conditions. Cholecystitis, or inflammation of the gallbladder, can be acute or chronic and is usually caused by gallstones. Gallbladder cancer is rare but associated with conditions like gallstones and chronic infection. Cancers can also occur in the bile ducts and ampulla of Vater.
Short bowel syndrome is a group of problems
related to poor absorption of nutrients that typically occurs in people who
have had half or more of their small intestine removed. The small intestine and
the large intestine, also called the colon, make up the bowel. The small
intestine is where most digestion of food and absorption of nutrients occur.
People with short bowel syndrome cannot absorb enough water, vitamins, and
other nutrients from food to sustain life.
This document discusses pathology related to the esophagus, including motor dysfunctions like achalasia, gastroesophageal reflux disease (GERD), Barrett's esophagus, and tumors. It describes the anatomy of the esophagus and principal symptoms of esophageal disorders such as heartburn, dysphagia, and odynophagia. Causes, diagnosis, and features of esophagitis, GERD, Barrett's esophagus, esophageal varices, and esophageal cancers including squamous cell carcinoma and adenocarcinoma are summarized. Risk factors, pathogenesis, histological findings, and prognosis of these conditions are also outlined.
A 17-year-old male presented with a 5-month history of abdominal pain and bloody mucus in his stool. Stool examination showed red blood cells, mucus, and pus cells but no pathogens. The patient experiences spontaneous remissions. The differential diagnosis includes inflammatory bowel disease. Further workup found the patient has inflammatory bowel disease, which is a chronic immune-mediated inflammation of the intestines that can manifest as ulcerative colitis or Crohn's disease. The document then discusses the epidemiology, pathogenesis, clinical features, pathology, and differences between ulcerative colitis and Crohn's disease in more detail.
The key points are:
- Peptic ulcers are chronic, solitary ulcers that occur where the gastrointestinal tract is exposed to gastric acid and pepsin, most commonly the duodenum and stomach.
- Risk factors include H. pylori infection, NSAID use, smoking, stress, and family history.
- Common symptoms are epigastric pain, nausea, vomiting, bleeding.
- Treatment involves eradication of H. pylori, PPIs, histamine blockers, and sometimes surgery for complications.
This document provides an overview of intestinal polyps. It begins with an introduction and relevant anatomy. Polyps are then classified based on size, attachment, and cellular architecture. Both non-neoplastic and neoplastic polyps are discussed. Non-neoplastic polyps include hyperplastic, juvenile, Peutz-Jeghers, inflammatory, Cronkhite-Canada, and Cowden polyps. Neoplastic polyps include adenomatous and syndromic polyps associated with Familial Adenomatous Polyposis (FAP) and Hereditary Nonpolyposis Colon Cancer (HNPCC). The pathogenesis and molecular biology of adenomatous polyps is also reviewed. Management strategies
Pancreatic endocrine tumors are rare, occurring in approximately 5 per 1,000,000 people per year. The most common types are insulinomas, gastrinomas, vipomas, and glucagonomas. Insulinomas typically present with hypoglycemic symptoms and are usually benign and solitary. Gastrinomas present with peptic ulcer disease and weight loss and are often malignant. Vipomas cause severe watery diarrhea and hypokalemia. Glucagonomas result in necrolytic migratory erythema, weight loss, and diabetes. Diagnosis involves laboratory tests and imaging like CT or MRI. Treatment depends on the type but may include surgery, chemotherapy, or symptom management. Progn
Ulcerative colitis and Crohn's disease are the two major types of inflammatory bowel disease. Ulcerative colitis only involves the colon while Crohn's disease can involve any part of the gastrointestinal tract. Both diseases involve chronic inflammation and can cause abdominal pain, diarrhea, and weight loss. Diagnosis involves blood tests, endoscopy, imaging, and biopsy. Treatments include medications to reduce inflammation like 5-aminosalicylates, corticosteroids, antibiotics, immunosuppressants, and biological therapies. Surgery may be required for complications or drug-resistant disease.
This document provides information on small and large intestine pathology. It discusses the normal anatomy and features of the small and large intestines. It then covers various pathologies that can affect the intestines including celiac disease, tropical sprue, Whipple's disease, amebic colitis, cryptosporidiosis, bacterial enterocolitis, ulcers of the intestine, granulomatous lesions, solitary rectal ulcer, Hirschsprung's disease, acquired megacolon, and appendicitis. For each condition, it provides details on pathogenesis, gross and microscopic pathology, clinical features, and diagnosis.
This document summarizes different types of gastric polyps, including solitary and polyposis syndromes. It describes epithelial polyps such as fundic gland, hyperplastic, and adenomatous polyps. It also discusses non-mucosal intramural polyps and polyposis syndromes. Specific polyp types such as adenomatous, hyperplastic, fundic gland, and Peutz-Jeghers polyps are defined. New syndromes associated with gastric polyposis and cancer risk such as GAPPS are introduced. The classification, histology, genetic causes, and cancer associations of different polyp types are concisely summarized.
The document discusses different types of intestinal volvulus including gastric, small bowel, large bowel, and combinations. Gastric volvulus is classified as organoaxial or mesenteroaxial depending on the axis of rotation. Small bowel volvulus often occurs due to midgut malrotation. Large bowel volvulus commonly affects the cecum or sigmoid colon. Sigmoid volvulus is the most common type of large bowel volvulus and presents as an inverted U-shape on imaging. Cecal volvulus results from torsion of the cecum around its own mesentery.
This document summarizes key information about various gastric conditions:
1) It describes acute and chronic gastritis, their causes, pathogenesis, and morphology.
2) It explains gastric ulcer, its types, causes, pathogenesis, and morphology.
3) It provides an overview of gastric carcinoma, including risk factors, pathogenesis, locations, histological types and clinical presentation.
This document discusses various types of colorectal polyps and polyposis syndromes. It begins by defining different types of colorectal polyps based on size, attachment, cellular architecture, and histological appearance. Larger polyps have a higher likelihood of harboring cancer. The main polyposis syndromes discussed are familial adenomatous polyposis (FAP), hereditary non-polyposis colorectal cancer (HNPCC), Peutz-Jeghers syndrome, and juvenile polyposis syndrome. FAP is characterized by hundreds of colonic polyps and a 100% risk of colon cancer. Management involves prophylactic colectomy and surveillance of other organs for extracol
Gastrointestinal stromal tumors (GISTs) arise from interstitial cells of Cajal in the gastrointestinal tract. Pathogenic mutations in KIT or PDGFRA genes drive tumor growth in most GISTs. GISTs most commonly occur in the stomach and small intestine. Microscopically, GISTs demonstrate spindle or epithelioid cell morphologies and strongly express KIT (CD117). Surgical resection is the primary treatment, while the tyrosine kinase inhibitor imatinib is effective for advanced or metastatic disease. Tumor size, mitotic rate, and site determine prognosis, with small intestinal GISTs having the worst outcomes.
This document contains the medical records of a 39-year-old female patient admitted with a 3-year history of abdominal pain and weakness. Physical examination revealed pallor. Laboratory tests showed anemia and elevated CEA. Imaging found thickening and masses in the colon concerning for cancer. The patient underwent a total proctocolectomy for Familial Adenomatous Polyposis (FAP) with carcinoma of the right colon. Pathology confirmed adenocarcinoma arising in adenomatous polyposis. The patient was discharged and started on chemotherapy due to lymph node involvement.
Gastric Cancer - Deifinition , epidemiology , histological types and molecular genetics and WHO update
Reference - WHO Classificiation of tumors of Digestive system
Rosai and Ackermann
This document provides an overview of colorectal cancer. It discusses that colorectal cancer is the third most common cancer globally. The document outlines the anatomy of the colon and risk factors for colorectal cancer such as pre-cancerous conditions, hereditary syndromes, diet, radiation exposure and surgeries. It also describes the pathology, clinical presentation, investigations and treatments for colorectal cancer. Staging systems including Duke's and TNM classification are summarized. The document concludes with an overview of how colorectal cancer spreads.
- Barrett's esophagus is characterized by intestinal metaplasia and dysplasia in the esophagus due to chronic acid reflux. It is a risk factor for esophageal adenocarcinoma.
- Histologically, it is defined by the presence of intestinal metaplasia above the esophagogastric junction, characterized by goblet cells interspersed among columnar epithelial cells. Low and high grade dysplasia may also be present and are characterized by nuclear abnormalities.
- Surveillance of Barrett's esophagus is important for early detection of neoplastic progression to allow for treatment before cancer develops. New techniques aim to improve in situ detection of neoplasia in Barrett's esoph
The document discusses tumors of the small and large intestines. It classifies intestinal tumors and provides details on various benign and malignant tumor types. The most common tumors are epithelial tumors, with colorectal cancer representing 70% of all gastrointestinal malignancies. Adenomas are precursors to most colorectal cancers. Risk factors include inflammatory bowel disease, familial polyposis, and diet. Prognosis and treatment depend on tumor stage and characteristics.
Colorectal carcinoma is the fourth most common cancer in males and third most common in females. It arises from the transformation of colorectal epithelial cells through a multi-step process involving mutations in genes like APC, KRAS, and p53. Pathological examination provides information on tumor stage, grade, and molecular characteristics that influence prognosis and guide treatment decisions. Molecular testing can also identify hereditary syndromes associated with colorectal cancer risk.
Colorectal cancer results from the accumulation of genetic mutations that progress from normal tissue to dysplastic adenomas to carcinoma over approximately 15 years. Patients with certain hereditary syndromes like familial adenomatous polyposis and hereditary non-polyposis colorectal cancer are at very high risk and require aggressive screening. Screening options for average risk patients include fecal occult blood testing, flexible sigmoidoscopy, and colonoscopy which can detect and remove precancerous polyps, reducing colorectal cancer incidence and mortality.
Short bowel syndrome is a group of problems
related to poor absorption of nutrients that typically occurs in people who
have had half or more of their small intestine removed. The small intestine and
the large intestine, also called the colon, make up the bowel. The small
intestine is where most digestion of food and absorption of nutrients occur.
People with short bowel syndrome cannot absorb enough water, vitamins, and
other nutrients from food to sustain life.
This document discusses pathology related to the esophagus, including motor dysfunctions like achalasia, gastroesophageal reflux disease (GERD), Barrett's esophagus, and tumors. It describes the anatomy of the esophagus and principal symptoms of esophageal disorders such as heartburn, dysphagia, and odynophagia. Causes, diagnosis, and features of esophagitis, GERD, Barrett's esophagus, esophageal varices, and esophageal cancers including squamous cell carcinoma and adenocarcinoma are summarized. Risk factors, pathogenesis, histological findings, and prognosis of these conditions are also outlined.
A 17-year-old male presented with a 5-month history of abdominal pain and bloody mucus in his stool. Stool examination showed red blood cells, mucus, and pus cells but no pathogens. The patient experiences spontaneous remissions. The differential diagnosis includes inflammatory bowel disease. Further workup found the patient has inflammatory bowel disease, which is a chronic immune-mediated inflammation of the intestines that can manifest as ulcerative colitis or Crohn's disease. The document then discusses the epidemiology, pathogenesis, clinical features, pathology, and differences between ulcerative colitis and Crohn's disease in more detail.
The key points are:
- Peptic ulcers are chronic, solitary ulcers that occur where the gastrointestinal tract is exposed to gastric acid and pepsin, most commonly the duodenum and stomach.
- Risk factors include H. pylori infection, NSAID use, smoking, stress, and family history.
- Common symptoms are epigastric pain, nausea, vomiting, bleeding.
- Treatment involves eradication of H. pylori, PPIs, histamine blockers, and sometimes surgery for complications.
This document provides an overview of intestinal polyps. It begins with an introduction and relevant anatomy. Polyps are then classified based on size, attachment, and cellular architecture. Both non-neoplastic and neoplastic polyps are discussed. Non-neoplastic polyps include hyperplastic, juvenile, Peutz-Jeghers, inflammatory, Cronkhite-Canada, and Cowden polyps. Neoplastic polyps include adenomatous and syndromic polyps associated with Familial Adenomatous Polyposis (FAP) and Hereditary Nonpolyposis Colon Cancer (HNPCC). The pathogenesis and molecular biology of adenomatous polyps is also reviewed. Management strategies
Pancreatic endocrine tumors are rare, occurring in approximately 5 per 1,000,000 people per year. The most common types are insulinomas, gastrinomas, vipomas, and glucagonomas. Insulinomas typically present with hypoglycemic symptoms and are usually benign and solitary. Gastrinomas present with peptic ulcer disease and weight loss and are often malignant. Vipomas cause severe watery diarrhea and hypokalemia. Glucagonomas result in necrolytic migratory erythema, weight loss, and diabetes. Diagnosis involves laboratory tests and imaging like CT or MRI. Treatment depends on the type but may include surgery, chemotherapy, or symptom management. Progn
Ulcerative colitis and Crohn's disease are the two major types of inflammatory bowel disease. Ulcerative colitis only involves the colon while Crohn's disease can involve any part of the gastrointestinal tract. Both diseases involve chronic inflammation and can cause abdominal pain, diarrhea, and weight loss. Diagnosis involves blood tests, endoscopy, imaging, and biopsy. Treatments include medications to reduce inflammation like 5-aminosalicylates, corticosteroids, antibiotics, immunosuppressants, and biological therapies. Surgery may be required for complications or drug-resistant disease.
This document provides information on small and large intestine pathology. It discusses the normal anatomy and features of the small and large intestines. It then covers various pathologies that can affect the intestines including celiac disease, tropical sprue, Whipple's disease, amebic colitis, cryptosporidiosis, bacterial enterocolitis, ulcers of the intestine, granulomatous lesions, solitary rectal ulcer, Hirschsprung's disease, acquired megacolon, and appendicitis. For each condition, it provides details on pathogenesis, gross and microscopic pathology, clinical features, and diagnosis.
This document summarizes different types of gastric polyps, including solitary and polyposis syndromes. It describes epithelial polyps such as fundic gland, hyperplastic, and adenomatous polyps. It also discusses non-mucosal intramural polyps and polyposis syndromes. Specific polyp types such as adenomatous, hyperplastic, fundic gland, and Peutz-Jeghers polyps are defined. New syndromes associated with gastric polyposis and cancer risk such as GAPPS are introduced. The classification, histology, genetic causes, and cancer associations of different polyp types are concisely summarized.
The document discusses different types of intestinal volvulus including gastric, small bowel, large bowel, and combinations. Gastric volvulus is classified as organoaxial or mesenteroaxial depending on the axis of rotation. Small bowel volvulus often occurs due to midgut malrotation. Large bowel volvulus commonly affects the cecum or sigmoid colon. Sigmoid volvulus is the most common type of large bowel volvulus and presents as an inverted U-shape on imaging. Cecal volvulus results from torsion of the cecum around its own mesentery.
This document summarizes key information about various gastric conditions:
1) It describes acute and chronic gastritis, their causes, pathogenesis, and morphology.
2) It explains gastric ulcer, its types, causes, pathogenesis, and morphology.
3) It provides an overview of gastric carcinoma, including risk factors, pathogenesis, locations, histological types and clinical presentation.
This document discusses various types of colorectal polyps and polyposis syndromes. It begins by defining different types of colorectal polyps based on size, attachment, cellular architecture, and histological appearance. Larger polyps have a higher likelihood of harboring cancer. The main polyposis syndromes discussed are familial adenomatous polyposis (FAP), hereditary non-polyposis colorectal cancer (HNPCC), Peutz-Jeghers syndrome, and juvenile polyposis syndrome. FAP is characterized by hundreds of colonic polyps and a 100% risk of colon cancer. Management involves prophylactic colectomy and surveillance of other organs for extracol
Gastrointestinal stromal tumors (GISTs) arise from interstitial cells of Cajal in the gastrointestinal tract. Pathogenic mutations in KIT or PDGFRA genes drive tumor growth in most GISTs. GISTs most commonly occur in the stomach and small intestine. Microscopically, GISTs demonstrate spindle or epithelioid cell morphologies and strongly express KIT (CD117). Surgical resection is the primary treatment, while the tyrosine kinase inhibitor imatinib is effective for advanced or metastatic disease. Tumor size, mitotic rate, and site determine prognosis, with small intestinal GISTs having the worst outcomes.
This document contains the medical records of a 39-year-old female patient admitted with a 3-year history of abdominal pain and weakness. Physical examination revealed pallor. Laboratory tests showed anemia and elevated CEA. Imaging found thickening and masses in the colon concerning for cancer. The patient underwent a total proctocolectomy for Familial Adenomatous Polyposis (FAP) with carcinoma of the right colon. Pathology confirmed adenocarcinoma arising in adenomatous polyposis. The patient was discharged and started on chemotherapy due to lymph node involvement.
Gastric Cancer - Deifinition , epidemiology , histological types and molecular genetics and WHO update
Reference - WHO Classificiation of tumors of Digestive system
Rosai and Ackermann
This document provides an overview of colorectal cancer. It discusses that colorectal cancer is the third most common cancer globally. The document outlines the anatomy of the colon and risk factors for colorectal cancer such as pre-cancerous conditions, hereditary syndromes, diet, radiation exposure and surgeries. It also describes the pathology, clinical presentation, investigations and treatments for colorectal cancer. Staging systems including Duke's and TNM classification are summarized. The document concludes with an overview of how colorectal cancer spreads.
- Barrett's esophagus is characterized by intestinal metaplasia and dysplasia in the esophagus due to chronic acid reflux. It is a risk factor for esophageal adenocarcinoma.
- Histologically, it is defined by the presence of intestinal metaplasia above the esophagogastric junction, characterized by goblet cells interspersed among columnar epithelial cells. Low and high grade dysplasia may also be present and are characterized by nuclear abnormalities.
- Surveillance of Barrett's esophagus is important for early detection of neoplastic progression to allow for treatment before cancer develops. New techniques aim to improve in situ detection of neoplasia in Barrett's esoph
The document discusses tumors of the small and large intestines. It classifies intestinal tumors and provides details on various benign and malignant tumor types. The most common tumors are epithelial tumors, with colorectal cancer representing 70% of all gastrointestinal malignancies. Adenomas are precursors to most colorectal cancers. Risk factors include inflammatory bowel disease, familial polyposis, and diet. Prognosis and treatment depend on tumor stage and characteristics.
Colorectal carcinoma is the fourth most common cancer in males and third most common in females. It arises from the transformation of colorectal epithelial cells through a multi-step process involving mutations in genes like APC, KRAS, and p53. Pathological examination provides information on tumor stage, grade, and molecular characteristics that influence prognosis and guide treatment decisions. Molecular testing can also identify hereditary syndromes associated with colorectal cancer risk.
Colorectal cancer results from the accumulation of genetic mutations that progress from normal tissue to dysplastic adenomas to carcinoma over approximately 15 years. Patients with certain hereditary syndromes like familial adenomatous polyposis and hereditary non-polyposis colorectal cancer are at very high risk and require aggressive screening. Screening options for average risk patients include fecal occult blood testing, flexible sigmoidoscopy, and colonoscopy which can detect and remove precancerous polyps, reducing colorectal cancer incidence and mortality.
1) The document discusses various precancerous lesions of the colon and rectum, including adenomas, hyperplastic polyps, sessile serrated lesions, and traditional serrated adenomas.
2) It describes the histological features and progression of these lesions, noting that sessile serrated lesions and traditional serrated adenomas have a significant malignant potential, whereas hyperplastic polyps have a very low malignant potential.
3) Two pathways of colorectal carcinogenesis are discussed: the classic adenoma-carcinoma sequence and the serrated neoplastic pathway, which involves certain serrated polyps.
This class covers what all physicians need to know about colorectal cancer (except prevention and screening, dealt with elsewhere). It is exceedingly simple, but accurate to the best of my knowledge. It is based on Harrison's 19th, Edition.
85% of gastric cancers are adenocarcinomas which can be diffuse or intestinal type. Diffuse cancers have worse prognosis and lack cell cohesion. Risk factors include dried foods, nitrates, H. pylori infection, and pernicious anemia. Symptoms include abdominal pain, weight loss, and anemia. Treatment involves surgery with D1 or D2 lymph node dissection and chemotherapy or chemoradiation for advanced or high risk cancers.
Colorectal cancer is the third most commonly diagnosed cancer worldwide. Risk factors include increasing age, family history, inflammatory bowel disease, lifestyle factors like obesity and smoking. Screening is recommended regularly beginning at age 50 to detect cancers early. Staging uses the TNM system and treatment depends on stage but commonly includes surgery along with chemotherapy and radiation for later stages. The document provides detailed information on epidemiology, risk factors, stages, diagnosis, treatment and screening guidelines for colorectal cancer.
- The document summarizes a seminar presentation on the molecular pathophysiology of colorectal cancer.
- Colorectal cancer is one of the most common cancers worldwide and its incidence is rising rapidly in Asia. It is the 4th most common cancer globally and the 2nd leading cause of cancer death.
- The molecular basis of colorectal cancer is complex, with different genetic and epigenetic pathways contributing to tumor development and progression, including chromosomal instability, microsatellite instability, and CpG island methylation. A better understanding of these pathways may help improve prevention and treatment strategies.
This document discusses tumors of the small and large intestines. It begins by describing non-neoplastic polyps such as hyperplastic, hamartomatous, inflammatory, and lymphoid polyps. It then discusses neoplastic epithelial lesions including benign adenomas and malignant adenocarcinoma, carcinoid tumors, squamous cell carcinoma, and malignant melanoma. Mesenchymal lesions such as gastrointestinal stromal tumor (GIST) and lymphoma are also reviewed. Specific topics covered in more depth include familial adenomatous polyposis, the adenoma-carcinoma sequence in colorectal carcinoma development, carcinoid tumors, gastrointestinal lymphoma, and TNM staging of colorectal carcinomas
This document discusses gastric cancer, including its incidence, risk factors, pathogenesis, clinical presentation, diagnostic evaluation, staging, and treatment approaches. Some key points include:
- Gastric cancer has a poor prognosis with only 20% 5-year survival. Early diagnosis is key.
- Risk factors include H. pylori infection, smoking, low socioeconomic status, and diets high in salt/preserved foods.
- Diagnosis involves endoscopy with biopsy. Staging evaluates tumor invasion and metastasis using CT, PET, and laparoscopy.
- Surgery offering total or subtotal gastrectomy is the only curative option, while chemotherapy and radiation are palliative.
This document summarizes rare and unusual types of urological cancers. It discusses rare subtypes of renal cell carcinoma defined by their histology and genetic abnormalities. It also describes rare histological variants of bladder cancer and non-urothelial cancers of the bladder such as squamous cell carcinoma, adenocarcinoma, small cell carcinoma, and lymphomas. Finally, it briefly outlines other rare non-urothelial cancers including sarcomas, carcinoid tumors, and other even less common malignancies of the bladder.
1) Familial adenomatous polyposis (FAP) is an autosomal dominant condition characterized by the development of hundreds to thousands of colonic polyps.
2) It is caused by a mutation in the APC gene and results in nearly 100% risk of colon cancer if left untreated.
3) Treatment involves prophylactic colectomy with either ileorectal anastomosis or restorative proctocolectomy with ileal pouch-anal anastomosis to remove the pre-cancerous colonic mucosa.
1. Colorectal cancer develops from adenomatous polyps over many years through the accumulation of genetic mutations in tumor suppressor genes, oncogenes, and DNA repair mechanisms.
2. The major hereditary colorectal cancer syndromes are familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer, which are associated with mutations in the APC and DNA MMR genes respectively.
3. Patients with inflammatory bowel disease or a family history of colorectal cancer are at increased risk of developing colorectal cancer.
Dear Viewers,
Greetings from " Surgical Educator"
Today in this video I am going to talk on one more cause for Lower GI hemorrhage- Colorectal Carcinoma. I talk on the various causes for Lower GI hemorrhage, Etiopathogenesis, clinical features, investigations, staging, treatment and followup of Colorectal carcinoma. I have also included a mindmap, a diagnostic algorithm and a treatment algorithm. Hope you will enjoy the video. You can watch the video in the following links:
surgicaleducator.blogspot.com
youtube.com/c/surgicaleducator
Thank you for watching the video.
The document discusses carcinoma of the pancreas. It covers the anatomy, epidemiology, risk factors, genetics, screening, staging, pathologic conditions, clinical presentation, evaluation, management approaches for resectable, borderline resectable, and unresectable disease, surgical procedures including Whipple procedure and distal pancreatectomy, complications, adjuvant therapy approaches studied in trials such as ESPAC-1, and the role of chemoradiation following gemcitabine chemotherapy.
1) The document discusses pancreatic neoplasms, including classification into exocrine and endocrine tumors.
2) It highlights adenocarcinoma of the pancreas, noting risk factors like smoking, chronic pancreatitis, genetics, and more.
3) Diagnosis involves imaging like CT/MRI, blood tests, and pathology examination of biopsies showing malignant cells and fibrosis.
Gastric carcinoma is the fourth most common cancer worldwide and the second leading cause of cancer death globally. It has a poor prognosis except in areas that conduct early screening. Approximately 95% are adenocarcinomas. Risk factors include H. pylori infection, smoking, genetic factors, and precancerous lesions. Staging involves endoscopy, CT, PET, and laparoscopy. Surgery with curative intent plus perioperative chemotherapy may cure early stage tumors. Advanced or metastatic disease is treated with palliative chemotherapy, radiation or surgery.
Pancreatic Carcinoma Classification and Preoperative evaluation in Whipple's ...Dr.Bhavin Vadodariya
The document discusses pancreatic tumor classification and preoperative evaluation for Whipple's procedure. It summarizes the main types of pancreatic tumors including pancreatic ductal adenocarcinoma, cystic neoplasms like serous cystic neoplasm and mucinous cystic neoplasm, and pancreatic neuroendocrine tumors. For preoperative evaluation, CT scan is useful for assessing resectability while ERCP may help with biliary decompression. Tissue biopsy is not always needed but can provide confirmation when the diagnosis is uncertain.
Colorectal cancer begins in the inner lining of the colon or rectum and can spread deeper into the wall of the colon/rectum and to other parts of the body. Risk factors include increasing age, family history, lifestyle factors like smoking, obesity, and lack of physical activity. Symptoms often include changes in bowel habits and bleeding. Screening is recommended regularly beginning at age 50. Treatment depends on the stage and may include surgery, radiation, chemotherapy, and targeted therapies. Prognosis depends on tumor stage and extent at diagnosis.
This document provides an overview of colon cancer, including its anatomy, epidemiology, risk factors, clinical features, screening, pathology, staging, diagnostic workup, treatment options, and management. Some key points include that colon cancer is the third leading cause of cancer deaths, adenocarcinoma makes up 98% of cases, and risk factors include age, diet low in fiber/high in fat, personal or family history, genetic factors, inflammatory bowel disease, and radiation exposure. Treatment involves surgery as the main treatment, with chemotherapy as an adjuvant for late stage or high-risk cases.
This document discusses the molecular biology of colorectal cancers. It notes that colorectal cancer results from the accumulation of genetic and epigenetic alterations in colonic epithelium that lead to adenocarcinoma. There are two main molecular pathways - the chromosomal instability pathway characterized by abnormalities like aneuploidy, and the microsatellite instability pathway where genes involved in DNA mismatch repair are mutated. The key genes and mutations involved in progression along these pathways are described, as well as biomarkers that have prognostic or predictive value for colorectal cancer.
Similar to Colorectal carcinoma gist carcinoid tumour (20)
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...rightmanforbloodline
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Versio
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
2. Gastro intestinal stromal tumor
(GIST)
Most common mesenchymal tumor of GIT
Differentiation along the line of INTESTINAL CELLS OF
CAJAL.
Most common location stomach 60% ,jejunum & ilium
30% duodenum 5% colorectum 5%.
common in 5th-8th decade of age
most cases of GIST show mutation in the receptor tyrosine
kinase KIT
may be associated with CARNEY TRIAD
about 50% of these tumors ulcerate and bleed.
IHC is done for KIT CD117
5. GI carcinoid
GI carcinoid is the most common primary tumor of
small bowel mostly in the APPENDIX.
GI carcinoid arise from ENTEROCHROMAFFIN
CELLS OF KULCHITSKY.
GROSS intramural or submucosal masses – small
polypoid lesion YELLOW OR TAN IN COLOR.
IHC tumor cells are positive for SYNAPTOPHYSIN ,
CHROMOGRANIN A.
7. GI LYMPHOMA
GI tract is the most common extranodal site for
lymphoma.
majority of GI lymphoma are B cell lymphoma in
response to infection or autoimmune process.
Seen in stomach 70%
small intestine 20%
ileocecal 10%
12. RISK FACTOR
INCREASING AGE OF THE PATIENT
DIET
HEREDITY
FAMILY HISTORY OF CRC IN 1ST DEGREE RELATIVE
PRIOR CRC OF THE PATIENT
H/O IBD OF THE PATIENT
IRRADIATION AND IMMUNOSUPRESSION OF THE
PATIENT
PHYSICAL INACTIVITY, OBESITY, SMOKING
13. Dietary factor, drug
low intake of dietary fiber less stool bulk slow
transit of stool bulk altered composition of intestinal
micro biota increased synthesis of toxic
oxidative(mutagen) , which remains in contact with the
colonic mucosa for long time.
Dietary high intake of refined carbohydrate and fat
increases chance of CRC.
Diet rich in cauliflower and cabbage and VIT A decreases
risk of CRC.
ASPIRIN OR NSAID reduces risk of CRC.
14. RISK FACTOR for colon cancer
GENETIC FACTOR
FAP patients have very high risk of colorectal cancer
FAP is autosomal dominant inherited syndrome
characterised by hundreds to thousands of polyps
throughout the colorectum. ( At least 100 polyps)
All untreated FAP patients develop colorectal cancer often
before age of 30 years.
HNPCC colorectal cancer in 1st degree relative of a patient
of colonic cancer is due to germline mutation in one of
the genes responsible for repair of DNA mismatch.
There is increased risk of colorectal cancer.
17. Risk factor for malignant change in
polyps of colon
PRE EXISTING NEOPLASTIC POLYPS INCREASES CHANCE
OF CRC
CRITERIA FOR INCREASED CHANCE OF CRC
large size of polyp( more than 2 cm)
villous architecture
dysplasia
multiple polyps ( more than 4 in number )
FAP patient will develop carcinoma in 95-100% cases (
highest malignant potential)
HNPCC patients will develop colorectal carcinoma in 70-75% of
cases
18. Pathogenesis of colon ca
Multiple molecular alterations are responsible
GENETIC ABNORMALITIES (that activate
oncogenes or inactivate tumor supressor gene).
EPIGENETIC ABNORMALITIES.
19. Genetic& epigenetic pathway
GENETIC PATHWAY
A classic adenoma-carcinoma sequence
B microsatellite instability pathway
EPIGENETIC ABNORMALITY
CpG island hypermethylation phenotype (CIMP )
Epigenetics is a reversible,heritable alteration in gene
expression which do not involve alteration in the DNA
sequence or it occurs without mutation
eg methylation of DNA
20. GENETIC FACTOR
Adenoma carcinoma sequence
Seen in 80% colonic carcinoma
This pathway is accompanied by a series of multiple
molecular alterations
According to this pathway the morphological
progression is a specific stepwise sequence from
normal mucosa to adenoma to invasive carcinoma
22. Adenoma-carcinoma sequence
MECHANISMS ARE
inactivation of APC tumour suppressor gene
K-RAS mutation
SMAD2 and SMAD4 mutation
mutation of TP53 tumour suppressor gene
activation of telomerase
23. Inactivation of APC tumor
supressor gene
APC gene or adenomatous polyposis coli gene
encodes a tumour suppressor protein
Normally APC causes degradation of β catenin in the
β catenin/WNT signalling pathway thus prevents
proliferation of cells
When APC gene is inactivated ABNORMAL
proliferation of cells takes place as in FAP
24. K-RAS mutation and SMAD2
SMAD4
Loss of APC function is followed by mutation of
K-RAS proto oncogene to K-RAS oncogene so
Cell proliferation increases
APOPTOSIS decreases
(KRAS kirsten rat sarcoma viral oncogene homolog)
SMAD2 AND SMAD4 are tumour suppressor gene and
inhibitor of cell proliferation loss of these genes may lead
to CRC .
25. GENETIC FACTOR
Microsatellite instability (due to
defective DNA repair )
microsatellites are repeated sequences of 1-6 nucleotides
in the genome. they become unstable during normal
cellular replication leading to insertion or deletion of bases
within these region.
DNA MISMATCH REPAIR GENE(MMR ) RAPIDLY
CORRECT THESE ERRORS TO MAINTAIN
MICROSATELLITE LENGTH.
Mutation in normal DNA repair genes ( mismatch repair
defect ) leads to accumulation of microsatellites referred to
as MSI about six MMR genes have been identified.
26. morphology
COLORECTAL CARCINOMA MAY BE
Located in any area of colon
IT MAY BE
exophytic cauliflower like polypoid mass in the
right side of colon
annular,constricting tumor in the left side of colon
diffuse,tubular tumor
infiltrative and ulcerating tumor
27.
28. Morphology cont.
• all colorectal carcinomas begin as in situ lesions
• tumors in the proximal colon: polypoid, exophytic
masses that extend along one wall of the cecum and ascending
colon
29. Morphology
cont.
• in the distal colon: annular, encircling lesions that
produce “napkin-ring” constrictions of the bowel and
narrowing of the lumen
31. microscopic picture of colorectal
adenocarcinoma (malignant cells are
arranged in glandular pattern)
32. WHO classification according to
microscopic type
Adenocarcinoma 95% ( usually infiltrating type)
Mucinous adeno carcinoma
Signet ring cell carcinoma
Adenosquamous carcinoma
Medullary carcinoma
Undifferentiated carcinoma
lymphoma
33. Clinical features of CRC
CARCINOMA OF THE LEFT SIDE
Alteration of bowel habit
Bleeding per rectum
Weight loss
Lower and LIF pain
CARCINOMA OF THE RIGHT SIDE
pain and palpable mass in RIF
Anaemia
melena in ulcerative form
Weight loss,nausea,vomiting,anorexia
34. Change in bowel habit in CRC
CLINICAL FEATURES
RIGHT COLON RECTUM LEFT COLON
Anaemia Tenesmus Constipation
Diarrhoea Blood & mucus PR Bleeding PR
35. Spread
1 DIRECT transverse,longitudinal ,radial spread to
adjacent organ
2 LYMPHATIC to regional lymph nodes
3 HAEMATOGENOUS to liver,lung ,brain
4 TRANSCOELOMIC via subperitoneal lymphatics to
other structures in the peritoneal cavity
36. Investigation in CRC
OCCULT BLOOD TEST IN STOOL
TUMOR MARKERS elevated level of
serum CEA (carcinoembryonic antigen) and serum
CA 19-9
sigmoidoscopy
colonoscopy
radiology DOUBLE CONTRAST BARIUM ENEMA
shows ‘ apple core appearance’
USG OF ABDOMEN
ABDOMINAL CT SCAN
37. PROGNOSTIC factor
Gross finding ( tumour size,local tumour extent, residual
tumour, circumferential margin)
TNM staging
Non-nodal tumour deposit
Tumour regression after neo adjuvant therapy
Lympho vascular ,perineural invasion
Histological type, grade of differentiation
Tumour border
Preoperative serum CEA level
MOST IMP PROGNOSTIC FACTORS ARE DEPTH OF
INVASION& PRESENCE OR ABSENCE OF LYMPH NODE
METASTASIS
38. Clinical problem
60 yrs old man having hypochromic anaemia
Stool shows presence of blood
In colonoscopy 4 cm bulky exophytic cauliflower like
polypoid mass seen projecting into caecum
biopsy and microscopic exam done DIAGNOSIS???
70 yr old man c/o change of bowel habit
Bleeding PR
In colonoscopy annular lesion encircling descending colon
is seen
Biopsy and microscopic exam done DIAGNOSIS???